Revvity Secures FDA Approval for Improved Automated Latent Tuberculosis Test
Go back to Revvity Secures FDA Approval for Improved Automated Latent Tuberculosis Test| PerkinElmer (NYSE: PKI) | Delayed: 115.24 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $115.24 | 52 Week High | $57.28 | |||
| Open | $1.73 | 52 Week Low | $39.50 | |||
| Day High | $115.24 | P/E | 78.93 | |||
| Day Low | $115.24 | EPS | $1.46 | |||
| Volume | 1,660 | |||||
| (NYSE: RVTY) | Delayed: 149.06 -3.83 (2.51%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $152.89 | 52 Week High | $ | |||
| Open | $155.48 | 52 Week Low | $ | |||
| Day High | $155.48 | P/E | N/A | |||
| Day Low | $148.31 | EPS | $ | |||
| Volume | 2,490,850 | |||||
